Clinical trials
Phase 2 Drug Resistant Epilepsy trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2008 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2018 | 2 |
| 2022 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Terminated | 3 |
| Enrolling by invitation | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Acorda Therapeutics | 1 |
| Biohaven Therapeutics Ltd. | 1 |
| Emory University | 1 |
| Madeline Fields | 1 |
| Mid-Atlantic Epilepsy and Sleep Center, LLC | 1 |
| Olive View-UCLA Education & Research Institute | 1 |
| SK Life Science, Inc. | 1 |
| UCB Biopharma S.P.R.L. | 1 |
| UCB Biopharma SRL | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Drug Resistant Epilepsy | 9 |
| Epilepsy | 6 |
| Seizures | 5 |
| Epilepsies, Partial | 2 |
| Autoimmune Diseases | 1 |
| Autoimmune Diseases of the Nervous System | 1 |
| Limbic Encephalitis | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.